Kaouthar Louati | Neuroscience | Excellence in Research Award

Kaouthar Louati | Neuroscience | Excellence in Research Award

Dr Kaouthar Louati, University of Monastir, Tunisia

Dr. Kaouthar Louati is a distinguished researcher and analytical chemist ๐ŸŽ“๐Ÿงช with a doctoral degree in Analytical Chemistry from the University of Monastir, Tunisia ๐Ÿ‡น๐Ÿ‡ณ. She has made substantial contributions to pharmaceutical sciences through over 15 high-impact publications ๐Ÿ“š, two book contributions ๐Ÿ“˜, and collaborative projects in Tunisia and the UK ๐Ÿ‡ฌ๐Ÿ‡ง. Her work focuses on toxicoproteomics, redox proteomics, and stability studies of pharmaceuticals ๐Ÿ’Š. Dr. Louati is affiliated with prestigious institutions including the University of Nottingham, Habib Bourguiba University Hospital, and multiple pharmaceutical laboratories ๐Ÿฅ๐Ÿ”ฌ. Known for her meticulous method validation, drug impurity analysis, and environmental toxicology studies ๐ŸŒฟโš—๏ธ, she has emerged as a key figure in analytical method development and toxicological risk assessment. With deep academic commitment and a passion for pharmaceutical innovation ๐Ÿ’ก, she continues to impact the global scientific community and serves as a role model for women in STEM ๐Ÿ‘ฉโ€๐Ÿ”ฌ๐ŸŒ.

Publication Profile

Orcid

Education

Dr. Louati’s academic journey is rooted in excellence ๐ŸŒŸ. She earned her Doctorate in Analytical Chemistry (2019โ€“2024) ๐Ÿงช from the University of Monastir, Tunisia, with very honorable distinction ๐ŸŽ“. Previously, she completed a Masterโ€™s in Medicamentsโ€™ Research and Development (2009โ€“2010) ๐Ÿงฌ and a Diploma in Doctor of Pharmacy (2008โ€“2009), both with high honors ๐Ÿ…. Her early academic path included a Diploma in Pharmacy (2002โ€“2007) with a very good grade ๐Ÿง‘โ€โš•๏ธ and a Mathematics Baccalaureate (2002) with very honorable mention ๐Ÿง โž•โž–. Throughout her education, she displayed strong scientific aptitude, particularly in pharmaceutical formulation, analytical chemistry, and medical science fundamentals ๐Ÿ’‰๐Ÿ“˜. This rich academic foundation positioned her to excel in multidisciplinary pharmaceutical research, bridging clinical applications with laboratory innovation ๐Ÿงซ๐Ÿ”.

Experience

Dr. Louati has extensive experience in academia, hospitals, and the pharmaceutical industry ๐Ÿฅ๐Ÿญ. Since 2020, she has served as a Doctor Pharmacist and Associate Researcher at the University of Monastir’s Laboratory of Pharmacology and Drug Development ๐Ÿ”ฌ, and at the Habib Bourguiba University Hospital in both the pharmaceutical and pathological anatomy departments ๐Ÿง‘โ€โš•๏ธ๐Ÿงซ. She also contributed internationally at the University of Nottingham and Royal Derby Hospital, UK (2020โ€“2023) ๐Ÿ‡ฌ๐Ÿ‡ง. From 2010 to 2015, she worked in UNIMED and PHARMACARE Laboratories, where she developed generic drugs, validated analytical methods, and ensured product compliance with international pharmacopeias ๐Ÿ’Š๐Ÿ“ˆ. Her expertise spans method validation (ICH Q2R1), stress testing, impurity profiling, and regulatory documentation โœ๏ธ๐Ÿ“‘. Her collaborative approach and technical leadership across diverse settings underscore her excellence as both a researcher and pharmaceutical scientist ๐ŸŒ๐Ÿงช.

Awards and Honors

Dr. Kaouthar Louati has earned academic distinction throughout her career, including โ€œVery Honorableโ€ mentions for both her doctoral and masterโ€™s studies ๐Ÿ…๐Ÿ“˜. She was recognized for producing highly cited research and has published over 15 peer-reviewed articles and 2 books in respected international journals and editions ๐Ÿ“š๐ŸŒ. Her contributions to method development, toxicological evaluation, and environmental health have received national and international attention ๐Ÿงฌ๐ŸŒ. Her scientific rigor earned her opportunities to collaborate with global institutions such as the University of Nottingham, reflecting peer recognition and trust in her expertise ๐Ÿค๐Ÿ”ฌ. Her work on toxicoproteomics and pharmaceutical impurities has made significant impacts on public health research and regulatory science ๐ŸŒก๏ธโš—๏ธ. Dr. Louatiโ€™s continued academic excellence, innovation, and mentorship potential position her as a prime candidate for the Best Researcher Award ๐Ÿ†๐ŸŽ–๏ธ.

Research Focus

Dr. Louatiโ€™s research is at the forefront of analytical chemistry, toxicoproteomics, and pharmaceutical sciences ๐Ÿ”๐Ÿงช. She focuses on validating and developing robust analytical methods to detect drug impurities, residual solvents, and degradation products, essential for drug stability and safety studies ๐Ÿ’Š๐Ÿ“ˆ. Her work in toxicoproteomics includes assessing oxidative stress and protein damage induced by environmental toxins like pesticides using cutting-edge techniques like Nano-UHPLC-MS/MS and 2D-SDS-PAGE ๐ŸŒฟ๐Ÿงฌ. She also pioneers method development for anti-epileptic drug monitoring and anabolic steroid detection for doping control ๐Ÿง ๐Ÿ’ช. Her integration of redox biology and pharmacological analytics strengthens both environmental health surveillance and clinical pharmacology ๐ŸŒŽ๐Ÿฅ. Dr. Louatiโ€™s unique blend of expertise bridges fundamental research with real-world applications, significantly contributing to public health, pharmacovigilance, and regulatory standards ๐ŸŒ๐Ÿ“Š.

Publication Top Notes

A Shotgun Proteomic-Based Approach with a Q-Exactive Hybrid Quadrupole-Orbitrap High-Resolution Mass Spectrometer for the Assessment of Pesticide Mixture-Induced Neurotoxicity on a 3D-Developed Neurospheroid Model from Human Brain Meningiomas: Identification of Trityl-Post-Translational Modification

ELENI KONSTANTINOPOULOU | Neuroscience | Best Researcher Award

ELENI KONSTANTINOPOULOU | Neuroscience | Best Researcher Award

Dr ELENI KONSTANTINOPOULOU, ARISTOTLE UNIVERSITY OF THESSALONIKI, Greece

Dr. Eleni Konstantinopoulou is a distinguished Psychologist ๐Ÿง‘โ€โš•๏ธ with expertise in Neuropsychology ๐Ÿงฌ. She earned her M.Sc. in Cognitive Psychology in 2010 and completed her Ph.D. in Neuropsychology in 2019 at the Aristotle University of Thessaloniki ๐Ÿ‡ฌ๐Ÿ‡ท. Her prolific research focuses on cognitive and psychological processes affected by neurological conditions, especially Frontotemporal Dementia ๐Ÿง . With over a decade of contributions at the 2nd Department of Neurology, she has led and supported numerous research projects in neuropsychology, cognitive psychology, and distance education ๐Ÿ“š. Dr. Konstantinopoulou has been both an academic scholar and clinical researcher, blending education and practice seamlessly. She actively contributes to the scientific community through publications, lectures, and collaborations ๐Ÿ”ฌ. Her work exemplifies excellence, innovation, and dedication to advancing brain health and cognitive rehabilitation ๐Ÿ’ก.

Publication Profile

Google Scholar

Education

Dr. Eleni Konstantinopoulou graduated with a degree in Psychology from the School of Psychology, Faculty of Philosophy at Aristotle University of Thessaloniki ๐ŸŽ“. She pursued her postgraduate studies in Cognitive Psychology, obtaining a Master of Science degree in 2010 ๐Ÿ“˜. Her intellectual passion led her to doctoral studies, culminating in a Ph.D. in Neuropsychology in 2019 ๐Ÿงช. During her academic journey, she honed her specialization in the neuropsychological impacts of degenerative brain disorders, with a specific focus on Frontotemporal Dementia ๐Ÿง . Her education has been marked by academic excellence, cross-disciplinary training, and a commitment to bridging the gap between cognitive theory and clinical application ๐Ÿ“–๐Ÿ”. Through continuous professional development and scholarly work, she has contributed to shaping future professionals and enhancing evidence-based practices in neuropsychology.

Experience

With over 14 years of combined clinical and academic experience, Dr. Konstantinopoulou has been a clinical and research fellow at the 2nd Department of Neurology at Aristotle University of Thessaloniki (2010โ€“2024) ๐Ÿฅ๐Ÿ”ฌ. She contributed as a research assistant and coordinator in various clinical trials and cognitive rehabilitation programs. Her teaching career includes roles as academic scholar at the University of Western Macedonia and Aristotle University, training future psychologists and clinicians ๐Ÿ‘ฉโ€๐Ÿซ๐Ÿ“˜. She has led neuropsychological assessments, contributed to diagnostic tools, and collaborated on multidisciplinary research involving MS and dementia. As a member of the Hellenic Neuropsychological Society ๐Ÿง ๐Ÿ‡ฌ๐Ÿ‡ท, she continues to advocate for clinical excellence and scientific advancement. Her postdoctoral research (2019โ€“2024) explored neuroanatomical correlations in Frontotemporal Dementia, further establishing her as a leader in the field. Her professional portfolio reflects depth, dedication, and impact across healthcare and academia ๐Ÿง‘โ€โš•๏ธ๐Ÿ“š.

Awards & Honors

Dr. Eleni Konstantinopoulouโ€™s work has received growing recognition in the domains of neuropsychology and cognitive rehabilitation ๐Ÿง ๐Ÿ…. While formal national or international awards are not listed, her impactful publications in high-ranking journals and her long-standing research collaboration in prominent neurology departments position her as an ideal candidate for the Best Researcher Award ๐Ÿฅ‡๐Ÿ“ˆ. Her involvement in the adaptation of Addenbrookeโ€™s Cognitive Examination-Revised for Greek populations is highly cited and influential ๐Ÿ‡ฌ๐Ÿ‡ท๐Ÿ“Š. Her role in the IGNITE study and other MS-related cognitive research further reflects her ability to bridge clinical practice with scientific inquiry ๐ŸŒ. She is respected in the Hellenic Neuropsychological Society and frequently collaborates on studies published in journals such as European Journal of Neurology, International Journal of Geriatric Psychiatry, and Journal of Neurological Sciences ๐Ÿ“‘๐ŸŒŸ. Her track record of excellence and collaborative spirit make her a standout candidate.

Research Focus

Dr. Konstantinopoulou’s research centers on the interplay between neurodegenerative diseases and cognitive function ๐Ÿง ๐Ÿ“‰. Her primary interest lies in understanding how conditions like Frontotemporal Dementia (FTD) and Multiple Sclerosis (MS) affect memory, executive function, behavior, and psychological well-being ๐Ÿงช๐Ÿงโ€โ™€๏ธ. She has explored neuropsychological profiles of different FTD variants, helping clinicians refine diagnoses and tailor interventions. Her postdoctoral work involved neuroanatomical mapping to link behavioral symptoms with structural brain changes using neuroimaging ๐Ÿงฌ๐Ÿง . She also engages in cognitive rehabilitation, testing computerized tools to improve MS patientsโ€™ cognitive abilities ๐Ÿ’ป๐Ÿง‘โ€โš•๏ธ. Her contributions to the adaptation of diagnostic tools like ACE-R for the Greek population enhance cross-cultural assessment and clinical accuracy ๐Ÿ‡ฌ๐Ÿ‡ท๐Ÿ“. Overall, her research supports early detection, better classification, and targeted cognitive therapies in neurology, impacting both clinical outcomes and scientific knowledge ๐ŸŒ๐Ÿ“Š.

Publication Top Notes

Adaptation of Addenbrookeโ€™s cognitive examinationโ€revised for the Greek population

The rationale for monitoring cognitive function in multiple sclerosis: practical issues for clinicians

Computerized cognitive rehabilitation for treatment of cognitive impairment in multiple sclerosis: an explorative study.

Behavioral disturbances differentiate frontotemporal lobar degeneration subtypes and Alzheimer’s disease: evidence from the Frontal Behavioral Inventory

The frontotemporal dementias in a tertiary referral center: classification and demographic characteristics in a series of 232 cases

Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: The IGNITE study

Early onset degenerative dementias: demographic characteristics and etiologic classification in a tertiary referral center

Changes in children’s beliefs about everyday reasoning: Evidence from Greek primary students.